Table 4. Long-term health sensitivity analysis.
| Life expectancy (years) | Quality adjusted life year (QALY) | Costs (RMB) | ICER | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Item | Liraglutide | Exenatide | Change | Liraglutide | Exenatide | Change | Liraglutide | Exenatide | Change | |
| Period | ||||||||||
| 30 years | 14.506 | 14.035 | 0.471 | 10.018 | 9.630 | 0.388 | 245227 | 247357 | -2130 | -11550 |
| 40 years | 14.869 | 14.313 | 0.556 | 10.221 | 9.779 | 0.442 | 424728 | 425876 | -1148 | -2597 |
| 50 years | 14.899 | 14.369 | 0.53 | 10.235 | 9.812 | 0.423 | 426491 | 428060 | -1569 | -3711 |
| Discount rate | ||||||||||
| 0% | 20.456 | 19.62 | 0.836 | 13.873 | 13.218 | 0.655 | 582046 | 582248 | -202 | -308 |
| 5% | 11.91 | 11.579 | 0.331 | 8.313 | 8.029 | 0.284 | 333277 | 339019 | -5742 | -20233 |
ICER, Incremental cost-effectiveness ratio.